LOGIN  |  REGISTER

Recent Insider Transactions - Travere Therapeutics (NASDAQ: TVTX)

Follow NASDAQ:TVTX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
02/12/2025
Sell
$23.53
5,200
$122K
98,519
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
02/12/2025
Sell
$23.53
8,000
$188K
89,482
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Buy
$15.46
15,000
$232K
78,654
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Buy
$17.44
10,000
$174K
73,654
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Buy
$16.23
10,000
$162K
73,654
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Buy
$17.96
10,000
$180K
73,654
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Sell
$25.00
15,000
$375K
63,654
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Sell
$25.00
9,244
$231K
54,410
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Sell
$16.23
10,000
$162K
0
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Sell
$17.44
10,000
$174K
0
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Sell
$17.96
10,000
$180K
0
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/11/2025
Sell
$15.46
15,000
$232K
0
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
02/11/2025
Sell
$25.00
3,074
$77K
127,634
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
02/12/2025
Sell
$23.53
2,568
$60K
125,066
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
02/11/2025
Sell
$24.04
11,375
$273K
419,173
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: CHIEF MEDICAL OFFICER
02/12/2025
Sell
$23.53
2,568
$60K
89,602
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
02/06/2025
Buy
$17.44
10,000
$174K
41,000
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
02/06/2025
Sell
$22.00
10,000
$220K
31,000
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
02/06/2025
Sell
$17.44
10,000
$174K
0
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
02/03/2025
Sell
$19.78
8,951
$177K
95,719
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
01/31/2025
Buy
$20.46
58,000
$1.187M
58,000
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
02/03/2025
Sell
$19.78
8,951
$177K
89,482
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
01/31/2025
Buy
$20.46
58,000
$1.187M
58,000
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
02/03/2025
Sell
$20.21
50,691
$1.024M
430,548
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
01/31/2025
Buy
$20.46
260,000
$5.320M
260,000
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: CHIEF MEDICAL OFFICER
01/31/2025
Buy
$20.46
100,000
$2.046M
100,000
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: CHIEF MEDICAL OFFICER
02/03/2025
Sell
$20.12
4,207
$85K
85,236
NASDAQ TVTX Travere Therapeutics
Inrig Jula / officer: CHIEF MEDICAL OFFICER
02/04/2025
Sell
$20.11
1,066
$21K
84,170
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
02/03/2025
Sell
$20.12
5,166
$104K
122,708
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
01/31/2025
Buy
$20.46
58,000
$1.187M
58,000
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
02/03/2025
Sell
$20.12
5,192
$104K
90,038
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
01/31/2025
Buy
$20.46
58,000
$1.187M
58,000
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
02/03/2025
Sell
$20.12
3,348
$67K
63,654
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
01/31/2025
Buy
$20.46
26,000
$532K
26,000
NASDAQ TVTX Travere Therapeutics
ROTE WILLIAM E. / officer: SENIOR VICE PRESIDENT, R&D
01/22/2025
Sell
$19.46
2,437
$47K
83,170
NASDAQ TVTX Travere Therapeutics
Dube Eric M / director, officer: CHIEF EXECUTIVE OFFICER
01/22/2025
Sell
$19.46
10,736
$209K
351,239
NASDAQ TVTX Travere Therapeutics
REED ELIZABETH E / officer: SVP, GC & CORPORATE SECRETARY
01/22/2025
Sell
$19.46
2,437
$47K
76,933
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
01/23/2025
Buy
$17.50
16,000
$280K
47,000
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
01/23/2025
Sell
$20.00
16,000
$320K
31,000
NASDAQ TVTX Travere Therapeutics
Baynes Roy D. / director
01/23/2025
Sell
$17.50
16,000
$280K
0
NASDAQ TVTX Travere Therapeutics
Heerma Peter / officer: CHIEF COMMERCIAL OFFICER
01/22/2025
Sell
$18.94
1,584
$30K
106,374
NASDAQ TVTX Travere Therapeutics
Cline Christopher R. / officer: CHIEF FINANCIAL OFFICER
01/22/2025
Sell
$18.94
865
$16K
73,730
NASDAQ TVTX Travere Therapeutics
Calvin Sandra / officer: SVP, CHIEF ACCOUNTING OFFICER
01/22/2025
Sell
$18.94
925
$18K
54,002

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous